C-Reactive protein in relation to fecundability and anovulation among eumenorrheic women

Radin RG, Sjaarda LA, Silver RM, Nobles CJ, Mumford SL, Perkins NJ, Wilcox BD, Pollack AZ, Schliep KC, Plowden TC, Schisterman EF

Published February 2018 Fertility and sterility, 109(2), 232-239.e1
DOI 10.1016/j.fertnstert.2017.10.025 PMID 29317123 PMC PMC5815923

RRM Academy Synopsis

Higher C-reactive protein linked to lower odds of pregnancy

This cohort study followed 572 healthy women trying to get pregnant after one or two pregnancy losses, in the placebo arm of a US aspirin trial. Higher C-reactive protein, a marker of inflammation, was linked with a lower chance of pregnancy each cycle. The marker was not linked with a higher rate of skipped ovulation.

Key Findings

  • Among 572 women in the placebo group, 2,022 menstrual cycles produced 348 pregnancies, a median of three cycles per woman.
  • Women in the highest third of C-reactive protein had a lower chance of pregnancy than the lowest third after adjusting for demographic factors (odds ratio 0.74, 95% CI 0.56-1.00).
  • After further adjusting for body mass index, the association weakened and its confidence interval crossed 1 (odds ratio 0.87, 95% CI 0.61-1.24).
  • C-reactive protein was not tied to a higher risk of skipped ovulation, adjusted for demographic factors (risk ratio 1.27, 95% CI 0.84-1.93) or body mass index (risk ratio 1.05, 95% CI 0.62-1.76).
  • 14.5% of the 1,019 cycles checked for ovulation in the first two cycles were cycles without ovulation.

Interpretation

Women with higher C-reactive protein had lower odds of pregnancy each cycle, even after the team adjusted for age, race, marital status, and time since pregnancy loss. The link grew weaker once body weight was added to the model. Body weight is closely tied to inflammation. Skipped ovulation rates were about the same across C-reactive protein levels, pointing away from ovulation as the reason for the pregnancy link. The authors note that most participants were white, which may limit how broadly the results apply. The findings support larger studies of inflammation and fertility in women without diagnosed infertility.

RRM Context

Restorative reproductive medicine considers the whole picture behind fertility. Body weight and inflammation are part of that picture. Cycle timing is only one piece. These factors can matter even when cycles are regular and there is no known cause for infertility.

Abstract

Objective

To assess systemic inflammation in relation to fecundability and anovulation.

Design

Prospective cohort study among participants in the Effects of Aspirin in Gestation and Reproduction trial who were assigned to the placebo.

Setting

Academic medical centers.

Patients

Healthy eumenorrheic women (n = 572), 18-40 years of age, with one or two pregnancy losses, attempting spontaneous pregnancy.

Interventions

Baseline serum high-sensitivity C-reactive protein (hsCRP) values <10 mg/L were categorized into tertiles.

Main Outcome Measures

Discrete Cox proportional hazards models estimated the fecundability odds ratio (FOR) and 95% confidence interval (CI) and adjusted for potential confounders. Log-binomial regression estimated the risk ratio (RR) and 95% CI of anovulation. The algorithm to define anovulation used data on urinary concentrations of hCG, pregnanediol-3-glucuronide, and LH as well as fertility monitor readings.

Results

Higher hsCRP was associated with reduced fecundability but not with an increased risk of anovulation.

Conclusions

Among healthy women attempting pregnancy after one or two pregnancy losses, we found preliminary evidence that systemic inflammation is associated with reduced fecundability, but not independently from adiposity. Sporadic anovulation did not appear to drive this association.

Trial Registration

ClinicalTrials.gov: NCT00467363.

By this author

Related research

Rose G Radin, Lindsey A Sjaarda, Robert M Silver, Carrie J Nobles, Sunni L Mumford, Neil J Perkins, Brian D Wilcox, Anna Z Pollack, Karen C Schliep, Torie C Plowden, Enrique F Schisterman
R Radin, L Sjaarda, Bob Silver, Rob Silver, Bobby Silver, R Silver, C Nobles, S Mumford, N Perkins, B Wilcox, A Pollack, K Schliep, T Plowden, E Schisterman
PMID 29317123 29317123 DOI 10.1016/j.fertnstert.2017.10.025 10.1016/j.fertnstert.2017.10.025 Radin et al. 2018, Radin 2018